Protective effects of dextromethorphan and tizanidine on ouabain-induced arrhythmias

Methods Find Exp Clin Pharmacol. 2002 Sep;24(7):421-3. doi: 10.1358/mf.2002.24.7.696543.

Abstract

The effects of the opioid agonist dextromethorphan and the alpha 2-adrenoceptor agonist tizanidine on ouabain-induced cardiac arrhythmias were investigated in rats. Ouabain (10 mg/kg i.v.) elicited ventricular arrhythmias in all of the control rats. Administration of dextromethorphan (25 mg/kg i.v.) and tizanidine (0.1 mg/kg i.v.) 30 min before ouabain treatment significantly reduced the incidence of arrhythmias. We suggest that dextromethorphan and tizanidine showed these effects by decreasing excitatory amino acid (EAA) activity. It can be speculated that opioids and other EAA antagonists may have antiarrhythmic actions through both their central and peripheral effects as well.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Animals
  • Arrhythmias, Cardiac / chemically induced
  • Arrhythmias, Cardiac / drug therapy*
  • Cardiotonic Agents / administration & dosage
  • Clonidine / analogs & derivatives*
  • Clonidine / pharmacology*
  • Dextromethorphan / pharmacology*
  • Dextromethorphan / therapeutic use
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Excitatory Amino Acid Antagonists / therapeutic use
  • Male
  • Ouabain / administration & dosage
  • Rats
  • Rats, Wistar

Substances

  • Adrenergic alpha-Agonists
  • Cardiotonic Agents
  • Excitatory Amino Acid Antagonists
  • Ouabain
  • tizanidine
  • Dextromethorphan
  • Clonidine